Lurasidone-induced anemia: Is there a need for hematological monitoring ?
We present two cases of schizophrenia, treated with lurasidone developing anemia after variable period of treatment and reverting after stopping lurasidone. These cases emphasize the timely monitoring of blood parameters for prevention or early detection of anemia in patients treated with lurasidone.
Source: Indian Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Vivek C Kirpekar Abhijeet D Faye Sudhir H Bhave Rahul Tadke Sushil Gawande Source Type: research
More News: Anemia | Bipolar | Depression | Drugs & Pharmacology | Hematology | India Health | Mania | Metabolic Syndrome | Schizophrenia